Caxton Associates (UK)’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,612
Closed -$351K 959
2026
Q1
$351K Buy
+3,612
New +$331K 0.01% 570
2025
Q2
Sell
-6,299
Closed -$449K 902
2025
Q1
$449K Buy
+6,299
New +$491K 0.02% 520

Other funds holding SRE

Caxton Associates (UK)'s SRE Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Sempra (SRE) in Q2 2026, closing a stake of 3,612 shares — an estimated $351K sold.

Caxton Associates (UK) first reported a position in SRE in Q1 2025 and held it in 2 quarters. The position peaked at $449K in Q1 2025. 1,282 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Sempra position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 3,612 Sempra shares in Q2 2026, an estimated $351K.
  • Caxton Associates (UK) first reported a position in Sempra in Q1 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Sempra position peaked at $449K in Q1 2025.
  • 1,282 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.